Quantbot Technologies LP increased its holdings in CBIZ, Inc. (NYSE:CBZ - Free Report) by 960.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 38,850 shares of the business services provider's stock after purchasing an additional 35,188 shares during the quarter. Quantbot Technologies LP owned 0.08% of CBIZ worth $2,614,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in the business. Burgundy Asset Management Ltd. grew its stake in shares of CBIZ by 1.8% during the second quarter. Burgundy Asset Management Ltd. now owns 2,220,013 shares of the business services provider's stock valued at $164,503,000 after buying an additional 40,215 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in CBIZ by 1.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,125,766 shares of the business services provider's stock worth $75,753,000 after acquiring an additional 11,401 shares during the last quarter. Premier Fund Managers Ltd grew its position in CBIZ by 14.0% during the 3rd quarter. Premier Fund Managers Ltd now owns 813,698 shares of the business services provider's stock worth $54,375,000 after acquiring an additional 100,000 shares during the last quarter. FMR LLC increased its stake in CBIZ by 27.4% in the 3rd quarter. FMR LLC now owns 594,660 shares of the business services provider's stock worth $40,015,000 after purchasing an additional 127,822 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in CBIZ by 1.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 525,330 shares of the business services provider's stock valued at $35,349,000 after purchasing an additional 9,872 shares during the last quarter. 87.44% of the stock is owned by institutional investors.
CBIZ Trading Down 0.7 %
NYSE:CBZ traded down $0.56 during mid-day trading on Thursday, reaching $82.44. 306,812 shares of the company's stock traded hands, compared to its average volume of 317,750. The company has a 50 day moving average price of $70.89 and a 200-day moving average price of $73.22. The firm has a market capitalization of $4.14 billion, a price-to-earnings ratio of 34.93 and a beta of 0.91. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 1.49. CBIZ, Inc. has a 12-month low of $57.01 and a 12-month high of $86.36.
CBIZ (NYSE:CBZ - Get Free Report) last posted its earnings results on Tuesday, October 29th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.08. CBIZ had a return on equity of 15.12% and a net margin of 7.08%. The firm had revenue of $438.90 million for the quarter, compared to analysts' expectations of $440.16 million. During the same period in the previous year, the firm earned $0.66 earnings per share. The business's revenue was up 6.9% compared to the same quarter last year. On average, sell-side analysts predict that CBIZ, Inc. will post 2.65 earnings per share for the current year.
Analysts Set New Price Targets
Several brokerages have recently issued reports on CBZ. StockNews.com cut shares of CBIZ from a "hold" rating to a "sell" rating in a report on Wednesday, November 20th. Sidoti raised shares of CBIZ from a "neutral" rating to a "buy" rating and raised their price target for the stock from $80.00 to $86.00 in a report on Monday, August 12th.
Get Our Latest Stock Analysis on CBIZ
CBIZ Profile
(
Free Report)
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Read More
Before you consider CBIZ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CBIZ wasn't on the list.
While CBIZ currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.